Toronto Dominion Bank Buys 69 Shares of Waters Co. (NYSE:WAT)

Toronto Dominion Bank increased its stake in shares of Waters Co. (NYSE:WAT) by 0.3% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 26,303 shares of the medical instruments supplier’s stock after acquiring an additional 69 shares during the period. Toronto Dominion Bank’s holdings in Waters were worth $9,466,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new position in shares of Waters during the 2nd quarter worth approximately $33,000. Kennebec Savings Bank acquired a new position in Waters during the third quarter worth $33,000. Blue Trust Inc. raised its position in Waters by 190.2% during the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 78 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Waters in the third quarter valued at $35,000. Finally, TFC Financial Management Inc. grew its position in shares of Waters by 19,900.0% in the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock valued at $58,000 after acquiring an additional 199 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. TD Cowen upped their target price on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday, November 4th. Barclays upped their price objective on Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a research note on Monday, November 4th. Stifel Nicolaus raised their price objective on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Wells Fargo & Company boosted their target price on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, Cfra set a $389.00 price target on Waters in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Waters presently has an average rating of “Hold” and an average target price of $375.85.

Waters Stock Down 1.2 %

WAT opened at $378.38 on Friday. The stock has a fifty day moving average of $366.04 and a 200-day moving average of $336.08. The company has a market capitalization of $22.47 billion, a P/E ratio of 36.10, a P/E/G ratio of 7.05 and a beta of 1.01. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $397.02. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02.

Waters (NYSE:WAT) last issued its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.25. The business had revenue of $740.30 million during the quarter, compared to analysts’ expectations of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.84 EPS. On average, equities analysts expect that Waters Co. will post 11.79 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.